Literature DB >> 33231809

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

Samantha J Mayo1,2, Maryam Lustberg3, Haryana M Dhillon4, Zev M Nakamura5, Deborah H Allen6, Diane Von Ah7, Michelle C Janelsins8,9,10, Alexandre Chan11, Karin Olson12, Chia Jie Tan13, Yi Long Toh13, Jeong Oh14, Lisa Grech15,16,17,18, Yin Ting Cheung19, Ishwaria Mohan Subbiah14, Duska Petranovic20, James D'Olimpio21, Margherita Gobbo22,23, Susanne Koeppen24, Charles L Loprinzi25, Linda Pang26, Shivani Shinde27, Olanipekun Ntukidem28, Katherine B Peters29.   

Abstract

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with non-central nervous system cancers throughout the disease and treatment trajectory. CRCI can have a substantial impact on the functional ability and quality of life of patients and their families. To mitigate the impact, oncology providers must know how to identify, assess, and educate patients and caregivers. The objective of this review is to provide oncology clinicians with an overview of CRCI in the context of adults with non-central nervous system cancers, with a particular focus on current approaches in its identification, assessment, and management.

Entities:  

Keywords:  CRCI; Cancer; Cancer-related cognitive impairment; Chemotherapy-related cognitive impairment; Cognition; Cognitive functioning

Mesh：

Year:  2020        PMID： 33231809     DOI： 10.1007/s00520-020-05860-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  114 in total

Review 1.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

2.  Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.

Authors:  S Mayo; H A Messner; S B Rourke; D Howell; J C Victor; J Kuruvilla; J H Lipton; V Gupta; D D Kim; C Piescic; D Breen; A Lambie; D Loach; F V Michelis; N Alam; J Uhm; L McGillis; K Metcalfe
Journal:  Bone Marrow Transplant       Date:  2016-02-29       Impact factor: 5.483

Review 3.  Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Debra Lynch Kelly; David Buchbinder; Rafael F Duarte; Jeffrey J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

4.  Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer.

Authors:  Val Shilling; Valerie Jenkins
Journal:  Eur J Oncol Nurs       Date:  2006-07-17       Impact factor: 2.398

Review 5.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

6.  Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature.

Authors:  Cay Anderson-Hanley; Marne L Sherman; Raine Riggs; V Bede Agocha; Bruce E Compas
Journal:  J Int Neuropsychol Soc       Date:  2003-11       Impact factor: 2.892

7.  Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

Authors:  J Vardy; J S Wefel; T Ahles; I F Tannock; S B Schagen
Journal:  Ann Oncol       Date:  2007-10-31       Impact factor: 32.976

8.  Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey.

Authors:  Marie Lange; Idlir Licaj; Bénédicte Clarisse; Xavier Humbert; Jean-Michel Grellard; Laure Tron; Florence Joly
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452

9.  Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.

Authors:  Nelli Boykoff; Mona Moieni; Saskia Karen Subramanian
Journal:  J Cancer Surviv       Date:  2009-09-16       Impact factor: 4.442

Review 10.  A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation.

Authors:  K M Phillips; H L McGinty; J Cessna; Y Asvat; B Gonzalez; M G Cases; B J Small; P B Jacobsen; J Pidala; H S L Jim
Journal:  Bone Marrow Transplant       Date:  2013-05-06       Impact factor: 5.483
View more
  18 in total

Review 1.  [Low anterior resection syndrome-Causes and treatment approaches].

Authors:  Sigmar Stelzner; Juliane Kupsch; Sören Torge Mees
Journal:  Chirurg       Date:  2021-04-20       Impact factor: 0.955

2. 

Authors:  Mansoureh Ashghali Farahani; Samira Soleimanpour; Samantha J Mayo; Jamie S Myers; Prabdeep Panesar; Farzaneh Ameri
Journal:  Can Oncol Nurs J       Date:  2022-02-01

3.  The effect of mind-body exercise on cognitive function in cancer survivors: A systematic review.

Authors:  Mansoureh Ashghali Farahani; Samira Soleimanpour; Samantha J Mayo; Jamie S Myers; Prabdeep Panesar; Farzaneh Ameri
Journal:  Can Oncol Nurs J       Date:  2022-02-01

4.  Cancer-related cognitive impairment: a mixed methods evaluation of a standard factsheet.

Authors:  Chloe Yi Shing Lim; Sharon He; Joanne Shaw; Haryana M Dhillon
Journal:  Support Care Cancer       Date:  2021-11-06       Impact factor: 3.603

5.  Temporal Dynamics of Resting-state Functional Networks and Cognitive Functioning following Systemic Treatment for Breast Cancer.

Authors:  Maryse J Luijendijk; Biniam M Bekele; Sanne B Schagen; Linda Douw; Michiel B de Ruiter
Journal:  Brain Imaging Behav       Date:  2022-06-15       Impact factor: 3.224

6.  Sustained effects of mantra meditation compared to music listening on neurocognitive outcomes of breast cancer survivors: A brief report of a randomized control trial.

Authors:  Ashley M Henneghan; Heather Becker; Carolyn Phillips; Shelli Kesler
Journal:  J Psychosom Res       Date:  2021-09-25       Impact factor: 3.006

7.  Understanding Longitudinal Changes in Cognitive Function in Lymphoma Patients: Where to Next?

Authors:  Janette L Vardy; Joanna Fardell
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 11.816

8.  Cognitive dysfunction prevalence and associated factors in older breast cancer survivors.

Authors:  Adele Crouch; Victoria L Champion; Frederick W Unverzagt; Susan J Pressler; Lesa Huber; Lyndsi R Moser; David Cella; Diane Von Ah
Journal:  J Geriatr Oncol       Date:  2021-07-08       Impact factor: 3.599

9.  Lung carcinoma-associated cognitive impairment in a patient with Alzheimer's disease pathology: A case report.

Authors:  Kiyoto Takigawa; Masahiko Takaya; Kazunari Ishii; Kazumasa Saigoh; Osamu Shirakawa
Journal:  Clin Case Rep       Date:  2021-07-06

10.  Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.

Authors:  Michelle C Janelsins; Mostafa Mohamed; Luke J Peppone; Allison Magnuson; Elizabeth K Belcher; Marianne Melnik; Shaker Dakhil; Jodi Geer; Charles Kamen; Lori Minasian; Patrick M Reagan; Supriya G Mohile; Gary R Morrow; Tim A Ahles; Charles E Heckler
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 11.816
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.